These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 10090431

  • 1. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
    Schenker H, Maloney S, Liss C, Gormley G, Hartenbaum D.
    Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
    [Abstract] [Full Text] [Related]

  • 2. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S, Mundorf TK, Stewart JA, Stewart WC.
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [Abstract] [Full Text] [Related]

  • 3. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
    Barnebey HS, Orengo-Nania S, Flowers BE, Samples J, Mallick S, Landry TA, Bergamini MV.
    Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
    [Abstract] [Full Text] [Related]

  • 4. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM, Bimatoprost Circadian IOP Study Group.
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Timolol maleate 0.5% versus timolol maleate in gel forming solution 0.5% (Timolol GFS) in open angle glaucoma in India. Preliminary safety and efficacy study.
    Kumar H, Sudan R, Sethi HS, Sony P.
    Indian J Ophthalmol; 2002 Mar; 50(1):21-3. PubMed ID: 12090082
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure.
    Stewart WC, Leland TM, Cate EA, Stewart JA.
    J Glaucoma; 1998 Dec; 7(6):402-7. PubMed ID: 9871862
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma.
    Halper LK, Johnson-Pratt L, Dobbins T, Hartenbaum D.
    J Ocul Pharmacol Ther; 2002 Apr; 18(2):105-13. PubMed ID: 12002664
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study.
    Shedden A, Laurence J, Tipping R, Timoptic-XE 0.5% Study Group.
    Clin Ther; 2001 Mar; 23(3):440-50. PubMed ID: 11318078
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
    Strohmaier K, Snyder E, Adamsons I.
    J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378
    [Abstract] [Full Text] [Related]

  • 17. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L.
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [Abstract] [Full Text] [Related]

  • 18. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.
    J Glaucoma; 2009 Apr; 18(4):293-300. PubMed ID: 19365194
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM, Williams RD, Snyder E, Adamsons IA.
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [Abstract] [Full Text] [Related]

  • 20. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
    Olander K, Zimmerman TJ, Downes N, Schoenfelder J, Xalacom/Latanoprost Study Group.
    Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.